This year’s Summit for Clinical Ops Executives (SCOPE) conference will feature a notable presence from CTTI as part of the annual meeting’s first-ever Sensors, Wearables and Digital Biomarkers in Clinical Trials track. The meeting will take place in Orlando from Feb. 12-15.
CTTI, which recently published a set of recommendations and resources for developing and incorporating novel technology-derived endpoints into clinical research as part of its larger Mobile Clinical Trials (MCT) Program, will lead a breakout session focusing on findings from this project and what they mean for site investigators and patients. Discussion will center on use cases developed from four therapeutic areas—Parkinson’s disease, heart failure, diabetes, and Duchennes muscular dystrophy—and will describe strategies for identifying, developing, and implementing novel endpoints derived from new and emerging technologies, including mobile devices.
The breakout session will be accompanied by a pair of related CTTI presentations taking place over the next two days. The first will provide insights from CTTI’s MCT Stakeholder Perceptions Project exploring patient and investigator views of research involving mobile technologies, and will examine ways to develop a successful patient-centered approach to leveraging mobile technology in clinical trials. The second presentation will offer expert perspectives from CTTI’s MCT Novel Endpoints Project, which addresses uncertainties about how best to incorporate mobile technologies into clinical research and offers pathways for leveraging data derived from such technologies to accelerate research and therapeutic development.
We hope you will join us in Orlando on Feb. 13-15 as we explore evidence-based approaches to integrating novel technologies and endpoints into clinical research.
Interactive Breakout Discussion: Selecting, Developing and Incorporating Novel Endpoints, Generated from Data Captured by Mobile Technologies, for Use in Clinical Trials
Date and time: Tues., Feb. 13, 4:00 p.m. EST
Presenters: Jennifer Goldsack (CTTI), Rob DiCicco (GSK), Amy Calvin (Eli Lilly), and Christian Gossens (Roche)
Presentation: New Findings on Patient and Site Perspectives from the Clinical Trials Transformation Initiative
Date and time: Thurs., Feb. 15, 12:25 p.m. EST
Presenter: Hassan Kadhim (Boehringer Ingelheim Pharmaceuticals)
Presentation: Identifying, Developing and Incorporating Technology-Derived Endpoints into Clinical Trials: A ‘How-To’ Guide
Date and time: Wed., Feb. 14, 11:15 a.m. EST
Presenter: Rob DiCicco (GSK)